age-related macular degeneration

FDA clears first treatment for dry AMD, with LumiThera’s Valeda

LumiThera’s Valeda system relies on photobiomodulation, or the use of different wavelengths of light to stimulate activity in the cells of the retina.

Conor Hale Nov 6, 2024 10:30am

Ionis axes eye disease from targets of Roche-partnered prospect

Aug 1, 2024 8:06am

Innovent's anti-VEGF drug matches Eylea in eye disease trial

Mar 19, 2024 10:36am

RetinAI Medical joins non-profit macular degeneration initiative

Nov 29, 2023 11:36am

'Unexpected' cataracts in ph. 3 end Kodiak's hopes for eye drug

Jul 24, 2023 8:58am

Annexon eye disease med failed phase 2 goal—the CEO is thrilled

May 24, 2023 4:01pm